Clinical Product Evaluation Policy (PDF)
TS4KSNFPVEZQ-89-5891
07/10/2020
WACHS
Policy
This policy outlines the process for the evaluation of introduction of clinical products into a clinical area to minimise these risks.
ON OUR SERVICES
ABOUT THIS WEBSITE